GL1X · GenesisL1 explorer

MolNFT v1 · #177050 · protein

Molecular basis for neutralizing antibody 2B11 targeting SARS-cov-2 rbd

7E5Y · Spike protein S1: “Molecular basis for neutralizing antibody 2B11 targeting SARS-cov-2 rbd”. X-ray diffraction, 10 pockets (best druggability 0.73). MolNFT v1 #177050 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7E5Y
Type
protein
Length
1,215 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike protein S1; 2B11 Fab light chain; 2B11 Fab heavy chain
UniProt
P0DTC2
Pockets
10 · best druggability 0.73

Structure

x-ray diffraction · 5 distinct chains · 8% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
R, ASpike protein S1protein18916% helix, 27% strandP0DTC2
L2B11 Fab light chainprotein2094% helix, 35% strand—
H2B11 Fab heavy chainprotein2063% helix, 49% strand—
B2B11 Fab light chainprotein2138% helix, 38% strand—
C2B11 Fab heavy chainprotein2097% helix, 47% strand—

Pockets

10 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15090.730.8259empty
24060.700.8152empty
34960.650.7765empty
44720.600.7446empty
52680.510.7538empty

Interfaces

7 interfaces between chains.

  • L–H · 1793 Ų buried · 11 hydrogen bonds · protein-protein
  • B–C · 1783 Ų buried · 12 hydrogen bonds · protein-protein
  • R–H · 849 Ų buried · 15 hydrogen bonds · protein-protein
  • A–C · 787 Ų buried · 23 hydrogen bonds · protein-protein
  • L–A · 721 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 16 disulfide (disulfide).

Compared structures

  • 7E5Y · Molecular basis for neutralizing antibody 2B11 targeting SARS-CoV-2 RBD · the same entry in another collection · chain R against R, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.